Tags |
|
|
Links |
|
|
E-Folder - Confessions of a Venture Capitalist
Venture Capitalists are often called Vulture Capitalists and until yo
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
u read the book: Confessions of a Venture Capitalist, Inside the high
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
-stakes world of start-up financing by Ruthann Quindlen; well you pro
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
bably will never understand how they got that slanderous title. In th
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
book Ruthann explains what it was like working in Silicon Valley in
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
a Venture Capital Company prior to the dot com bubble burst.
If you
If you
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
are considering getting venture capital for your startup company then
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
perhaps you should read this book. After all would you like to sit d
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
own for a cup of coffee with a venture capitalist who has been in the
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
industry for years before you go in pitch your business plan? In th
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
book they describe how venture capitalists will work with many compa
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
nies at one time expecting that one or two may make it to a huge payo
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ut. The rest they expect to either break even or lose money and they
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
will eventually dump.
The world of venture capitalists is about ret
The world of venture capitalists is about ret
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
rn on investment in a very short time period and they are not looking
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
for just making a profit they are looking to make 10 times or more t
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
he money they invested. There are many venture capital firms and ofte
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
they bet on the jockey and not just the horse. A business idea or c
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
oncept may be very good, but if the entrepreneur is unworkable the ve
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
nture capitalists will have to pass. Please consider all this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/46633/e-folder-Confessions-of-a-Venture-Capitalist.html">Confessions of a Venture Capitalist</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/46633/e-folder-Confessions-of-a-Venture-Capitalist.html]Confessions of a Venture Capitalist[/url]
Related Articles:
Do You Make a Good Impression - 10 Tips to Make Sure You Do
Managers: Think You've Got Total PR?
Childcare Finances - Some Money Basics
Bookmark it:
|